QQ客服 官方微博 反馈留言

	Physcion 8-O-β-glucopyranoside inhibits clear-cell renal cell carcinoma bydownregulating hexokinase II and inhibiting glycolysis
	Wang Q.; Yan Y.; Zhang J.; Guo P.; Xing Y.; Wang Y.; Qin F.; Zeng Q.
刊名	Biomedicine and Pharmacotherapy
	2018
卷号	104页码:28-35
关键词	Apoptosis ccRCC Glycolysis HK2 PG
DOI	10.1016/j.biopha.2018.05.013
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4582561
专题	山东大学
作者单位	1.Shandong Provincial Hospital affiliated to Shandong University, Jinan, Shandong, China 2.Shandong Provincial Hospital affiliated to
推荐引用方式 GB/T 7714	Wang Q.,Yan Y.,Zhang J.,et al. Physcion 8-O-β-glucopyranoside inhibits clear-cell renal cell carcinoma bydownregulating hexokinase II and inhibiting glycolysis[J]. Biomedicine and Pharmacotherapy,2018,104:28-35.
APA	Wang Q..,Yan Y..,Zhang J..,Guo P..,Xing Y..,...&Zeng Q..(2018).Physcion 8-O-β-glucopyranoside inhibits clear-cell renal cell carcinoma bydownregulating hexokinase II and inhibiting glycolysis.Biomedicine and Pharmacotherapy,104,28-35.
MLA	Wang Q.,et al."Physcion 8-O-β-glucopyranoside inhibits clear-cell renal cell carcinoma bydownregulating hexokinase II and inhibiting glycolysis".Biomedicine and Pharmacotherapy 104(2018):28-35.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。